Contributions of Fasting and Postprandial Glucose Concentrations to Haemoglobin A1c in Drug-Naïve Mal-Glucose Metabolism in Chinese Population Using Continuous Glucose Monitoring System
Table 1
Characteristics of all prediabetes and T2D patients over groups of HbA1c.
HbA1c Groups
IGT/IFG
Quintiles of glycated haemoglobin in T2D patients
Total
0
1
2
3
4
5
Number
10
61
55
55
62
62
305
Age (yrs)
41.1 ± 19.4
53.2 ± 10.9
53.3 ± 12.3
52.0 ± 9.3
50.3 ± 10.6
48.8 ± 10.8
51.1 ± 11.4
Sex (M/F)
5/5
42/19
40/15
36/19
40/22
45/17
208/97
Body mass index (kg/m2)
28.4 ± 8.3
25.7 ± 3.1
25.7 ± 3.2
25.9 ± 3.5
25.2 ± 2.7
23.9 ± 3.5
25.3 ± 3.5
Haemoglobin (g/L)
137.3 ± 13.9
142.9 ± 16.9
144.6 ± 14.6
144.7 ± 18.4
144.7 ± 13.2
141.1 ± 12.2
143.4 ± 15.1
Fasting glucose (mmol/L)
5.6 ± 0.9
7.8 ± 1.8
9.2 ± 2.0
9.2 ± 1.5
10.7 ± 2.0
11.1 ± 2.5
9.5 ± 2.4
AUCtotal (mmol/L·day)
0.57 ± 0.45
3.35 ± 1.84
4.63 ± 2.05
5.21 ± 1.75
6.50 ± 2.29
6.78 ± 2.69
5.16 ± 2.60
AUCFG (mmol/L·day)
0.20 ± 0.25
1.61 ± 1.49
2.87 ± 1.78
2.84 ± 1.44
4.26 ± 1.90
4.51 ± 2.38
3.14 ± 2.16
AUCPG (mmol/L·day)
0.43 ± 0.43
1.78 ± 1.12
1.79 ± 0.96
2.38 ± 1.13
2.25 ± 1.12
2.27 ± 1.12
2.04 ± 1.14
FG contribution (%)
7.73 ± 14.69
39.71 ± 28.06
56.72 ± 24.27
53.22 ± 17.96
64.08 ± 16.32
62.54 ± 20.15
53.76 ± 24.64
PG contribution (%)
92.27 ± 14.69
60.29 ± 28.06
43.28 ± 24.27
46.78 ± 17.96
35.92 ± 16.32
37.47 ± 20.15
46.24 ± 24.64
Mean glycated haemoglobin (%)
5.5 ± 0.4
7.3 ± 0.5
8.3 ± 0.3
9.1 ± 0.2
10.1 ± 0.4
12.1 ± 0.9
9.3 ± 1.9
Range of glycated haemoglobin (%)
4.9–6.0
6.1–7.8
7.9–8.7
8.8–9.5
9.6–10.9
11.0–14.6
4.9–14.6
Data are mean ± SD. Significant differences from the lower quintile.
